Cytel

We’re excited to welcome Scott Rogers as Cytel’s new Chief Financial Officer. Scott brings a unique blend of financial leadership and deep experience in clinical development, having served as CFO at Saama and as Senior Vice President of Clinical Finance at PPD. His passion for using finance to unlock innovation will help guide Cytel as we continue to transform clinical trial design and data science. Please join us in giving Scott a warm welcome! Discover more: https://hubs.ly/Q03Lk2XZ0

Our team is ready for another exciting day at SCDM 2025! If you're joining us at SCDM 2025, make sure to drop by booth 528 and discover how we're empowering life science leaders to realize the full potential of their therapies! Discover how our data management solutions drive smarter clinical trials. From data smart strategy to proven execution-we unlock the full value of patient data to drive success you can trust. Book your meeting: https://hubs.ly/Q03Lj6Ky0 #SCDM #ClinicalTrials Noah Orlian Kritika Khurana Jackie Dowell, MBA Bill Baker Jennifer Sustin KC Morris

For our latest Career Perspectives interview, we are delighted to feature Naydene Slabbert, Principal Clinical Data Manager. Naydene discusses the critical role of early-stage clinical trial setup in ensuring the delivery of high-quality, actionable data and reflects on the evolving role of data managers in clinical trials. Read the full interview: https://hubs.ly/Q03L1N_f0

In early development, time and patient availability are often limited and traditional randomized controlled trials (RCTs) aren’t always feasible or sufficient. Small populations, ethical considerations, and the pressing need to deliver therapies faster make it increasingly difficult to generate the comparative evidence required for confident decision-making. External control arms (ECAs) offer a powerful alternative to traditional trial designs. By leveraging data from single-arm studies, post-market evidence, and real-world sources, ECAs enable smaller, more efficient trials without the need for a concurrent control group. Join us for this insightful webinar to learn from Dr. Alexander Schacht, Steven Ting & Vahé Asvatourian when and why ECAs make sense, how to evaluate and integrate the right data sources, and the strategies that ensure credibility and regulatory acceptance Register here: https://hubs.ly/Q03L7jPl0

After the first day filled with our presentations and interesting insights, our team is ready to go for day 2 of the 2025 ASA Biopharmaceutical Section Regulatory-Industry Statistics Workshop! Make sure to drop by booth 5 and discover how we are empowering life science leaders to realize the full potential of their therapies. Book your meeting here: https://hubs.ly/Q03K-0FR0 #ASA #Biostatistics Boaz Adler J. Kyle Wathen Subhajit Sengupta, Ph.D. Walter Boyle Cyrus Mehta

Global HTA bodies are setting higher standards for rigorous evidence to support access decisions, but traditional modeling techniques often fall short, prompting the need for more advanced and adaptable approaches. Hoora Moradian, PhD, Victor Laliman-Khara, Peter Wigfield, Mike Dolph, and Michael Groff discuss finding the right method for various market access scenarios, given your indication, patient population characteristics, and data gaps. Read the post to learn more: https://lnkd.in/ebvgQM4U Hoora, Victor, Peter, Mike, and Michael, along with moderator Angie Raad-Faherty will hosting a webinar on this topic on October 9. Use the link above to register today! #HTA #data #quantitativemethods #pharma #biotech

Is there an ongoing tension between different generations in the workforce? Especially between Gen Z, who’s believed to prioritize flexibility, mental health, and efficiency, and older generations who is believed to favour long hours and strict adherence to traditional office protocols? Discover everything about it during Jennifer Sustin's presentation at SCDM "Generations and Culture – How Prepared are We to Welcome the Next Gen Workforce" on Monday September 29! While you're there, make sure to drop by booth 528 and discover how our data management solutions drive smarter clinical trials. From data smart strategy to proven execution-we unlock the full value of patient data to drive success you can trust. Book your meeting here: https://hubs.ly/Q03KLslq0

In drug development, chemistry isn’t just the first “C” in CMC, it’s the engine that powers everything else. Bengt Hedin discusses key elements, regulatory and commercial perspectives, and how it all starts, and sometimes ends, with the molecule. Read the post to learn more: https://hubs.ly/Q03Ky0J70 #CMC #chemistry #drugdevelopment

Joining the Cytel Team at NLS Days 2025? Make sure to connect with our colleagues Anna Torrång, Alena Shubina and Ulrika Andersson at booth 01:02 while you're there and discover how we are empowering life science leaders to realize the full potential of their therapies! Book your meeting: https://hubs.ly/Q03KwBHS0 #NLSDays #ClinicalTrials

We’re proud to announce that Cytel is a finalist for the Scrip Award for Best CRO Specialist Providers! Discover more on https://hubs.ly/Q03KvJfb0 #ScripAwards #Cytel #ClinicalResearch #Biostatistics #AdaptiveTrials